A site-directed mutagenesis study on the conserved alanine residue in the distal third intracellular loops of cholecystokinin(B) and neurotensin receptors

British Journal of Pharmacology

Volumn 121, Issue 2, 1997, Pages 310-316

  Wang, Hung Li ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Ca2+ activated chloride currents; CCK(B) receptors; G(q) proteins; Inositol phosphates; Neurotensin; Neurotensin receptors; Phospholipase C; Sulphated cholecystokinin octapeptide

Indexed keywords

ALANINE; CHOLECYSTOKININ B RECEPTOR; GLUTAMIC ACID; INOSITOL PHOSPHATE; NEUROTENSIN RECEPTOR; PHOSPHOLIPASE C;

ANIMAL CELL; ARTICLE; CHLORIDE CURRENT; FEMALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; XENOPUS;

EID: 0030946353     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701117     Document Type: Article

References (40)

1. BENYA, R.V., AKESON, M., MROZINSKI, J., JENSEN, R. & BATTEY, J.F. (1994). Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and-independent processes. Mol. Pharmacol., 46, 495-501.
2. BERRIDGE, M.J. (1993). Inositol trisphosphate and calcium signaling. Nature, 361, 315-321.
3. q/11 by the m3 muscarinic acetylcholine receptor. J. Biol. Chem., 270, 17741-17748.
4. BLUML, K., MUTSCHLER, E. & WEISS, J. (1994). Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. Proc. Natl. Acad. Sci. U.S.A., 91, 7980-7984.
5. BURSTEIN, E.S., SPALDING, T.A., HILL-EUBANKS, D. & BRANN, M.R. (1995). Structure-function of muscarinic receptor coupling to G proteins: random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins. J. Biol. Chem., 270, 3141-3146.
6. CHABRY, J., LABBE-JULLIE, C., GULLY, D., KITABGI, P., VINCENT, J.P. & MAZELLA, J. (1994). Stable expression of the cloned rat brain neurotensin receptor into fibroblasts: Binding properties, photoaffinity labeling, transduction mechanisms, and internalization. J. Neurochem., 63, 19-27.
7. CHANG, R.S.L. & LOTTI, V.J. (1991). Ligands for cholecystokinin A and cholecystokinin B/gastrin receptors. In Methods in Neuroscience, Vol 5. ed. Cone, M., pp. 479-493. New York: Academic Press Inc.
8. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. U.S.A., 87, 2896-2900.
9. CULLEN, B.R. (1987). Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol., 152, 684-704.
10. GODFREY, P.P. (1992). Methods for the analysis of phosphoinositides and inositol phosphates. In Intracellular Messengers, Neuromethods Vol. 20. ed. Boulton, A., Baker, G. & Taylor, C., pp. 57-78. The Human Press Inc.
11. HELPER, J.R. & GILMAN, A.G. (1992). G proteins. Trends Biochem. Sci., 17, 383-387.
12. o by mastoparan, related amphiphilic peptides, and hydrophohic amines. J. Biol. Chem., 265, 14176-14186.
13. HILL-EUBANKS, D., BURSTEIN, E.S., SPALDING, T.A., BRAUNER-OSBORNE, H. & BRANN, M.R. (1996). Structure of a G-protein-coupling domain of a muscarinic receptor predicted by a random saturation mutagenesis. J. Biol. Chem., 271, 3058-3065.
14. HUGHES, J., BODEN, P., COSTALL, B., DOMENEY, A., KELLY, E., HORWELL, D.C., HUNTER, J.C., PINNOCK, R.D. & WOODRUFF, G.N. (1990). Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A., 87, 6728-6733.
15. ITO, W., ISHIGURO, H. & KUROSAWA, Y. (1991). A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. Gene, 102, 67-70.
16. 100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. Mol. Pharmacol., 48, 783-789.
17. 1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem., 267, 1430-1433.
18. KOPIN, A.S., LEE, Y.-M., MCBRIDE, E., MILLER, L.J., LIN, H., KOLAKOWSKI, L.E. & BEINBORN, M. (1992). Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. U.S.A., 89, 3605-3609.
19. KOSUGI, S., OKAJIMA, R., BAN, A., HIDAKA, A., SHENKER, A. & KOHN, L.D. (1992). Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin receptors results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J. Biol. Chem., 262, 24153-24156.
20. KUNKEL, M.T. & PERALTA, E.G. (1993). Charged amino acids required for signal transduction by the m3 muscarinic acetylcholine receptor. EMBO J., 12, 3809-3815.
21. LECHLEITER, J., HELLMISS, R., DUERSON, K., ENNULAT, D., DAVID, N., CLAPHAM, D. & PERALTA, E. (1990). Distinct sequence elements control the specificity of G protein by muscarinic acetylcholine receptor subtypes. EMBO J., 9, 4381-4390.
22. LEE, Y.M., BEINBORN, M., MCBRIDE, E.W., LU, M., KOLAKOWSKI, L.F. & KOPIN, A.S. (1993). The human brain cholecystokinin-B/ gastrin receptor. J. Biol. Chem., 268, 8164-8172.
23. 2-adrenergic receptors based on characteristics in primary structure. J. Biol. Chem., 267, 8342-8346.
24. 2+. J. Physiol., 408, 223-232.
25. 2-adrenergic receptor: How structure elucidates function. Annu. Rev. Pharmacol., 32, 167-183.
26. SAVARESE, T.M. & FRASER, C.M. (1992). In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J., 283, 1-19.
27. SIGEL, E. (1990). Use of Xenopus oocytes for the functional expression of plasma membrane proteins. J. Memb. Biol., 117, 201-221.
28. STRADER, C.D., FONG, T.M., MICHAEL, R.T., UNDERWOOD, D. & DIXON, R.A.F. (1994). Structure and function of G protein-coupled receptors. Annu. Rev. Biochem., 63, 101-132.
29. SUKUMAR, M. & HIGASHIJIMA, T. (1992). G protein-bound conformation of mastoparan-X, receptor-mimetic peptide. J. Biol. Chem., 267, 21421-21424.
30. TANAKA, K., MASU, M. & NAKANISHI, S. (1990). Structure and functional expression of the cloned rat neurotensin receptor. Neuron, 4, 847-854.
31. VITA, N., LAURENT, P., LEFORT, S., CHALON, P., DUMONT, X., KAGHAD, M., GULLY, D., LE FUR, G., FERRARA, P. & CAPUT, D. (1993). Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett., 317, 139-142.
32. q coupling by the use of receptor chimeras. J. Biol. Chem., 270, 16677-16682.
33. αq 11 mediates neurotensin excitation of substantia nigra dopaminergic neurons. Mol. Brain Res., 36, 29-36.
34. WANK, S.A., HARKINS, R., JENSEN, R., SHAPIRA, H., DE WEERTH, A. & SLATTERY, T. (1992a). Purification, molecular cloning, and functional expression of the cholecystokinin receptors from rat pancreas. Proc. Natl. Acad. Sci. U.S.A., 89, 3125-3129.
35. WANK, S.A., PISEGNA, J.R. & DE WEERTH, A. (1992b). Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc. Natl. Acad. Sci. U.S.A., 89, 8691-8695.
36. s in response to muscarinic agonists. J. Biol. Chem., 265, 6219-6224.
37. WU, T., LI, A. & WANG, H.L. (1995). Neurotensin increases the cationic conductance of rat substantia nigra dopaminergic neurons through the inositol (1,4,5) trisphosphate-calcium pathway, Brain Res., 683, 242-250.
38. WU, T. & WANG, H.L. (1995). Protein kinase C mediates neurotensin inhibition of inwardly rectifying potassium currents in rat substantia nigra dopaminergic neurons. Neurosci. Lett., 184, 121-124.
39. WU, T. & WANG, H.L. (1996). The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms. Eur. J. Pharmacol., 307, 125-132.
40. YAMADA, M., YAMADA, M., WATSON, M.A. & RICHELSON, E. (1994). Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells. Mol. Pharmacol., 46, 470-476.